ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Innovative Drug Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-15T5957
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Innovative Drug Market Report Forecast 2022 2028
BUY CHAPTERS

Global Innovative Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-15T5957
Report
December 2024
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline(GSK )
Amgen Inc
Astrazeneca plc
Bristol–Myers Squibb
Eli Lilly
TEVA
Bayer
Novo Nordisk
Allergan plc
Takeda
Boehringer Ingelheim

Innovative Drug Market Size

The global Innovative Drug market is projected to grow from US$ 21900 million in 2024 to US$ 30720 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.

Innovative Drug Market

Innovative Drug Market

Innovative drugs refer to drugs with proprietary intellectual property rights.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Innovative Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Innovative Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Innovative Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Innovative Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Innovative Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Innovative Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Innovative Drug Market Report

Report Metric Details
Report Name Innovative Drug Market
Accounted market size in 2024 US$ 21900 million
Forecasted market size in 2030 US$ 30720 million
CAGR 5.8
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Pharmacy
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Allergan, Takeda, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Innovative Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Innovative Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Innovative Drug sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Innovative Drug Market growing?

Ans: The Innovative Drug Market witnessing a CAGR of 5.8 during the forecast period 2025-2030.

What is the Innovative Drug Market size in 2030?

Ans: The Innovative Drug Market size in 2030 will be US$ 30720 million.

Who are the main players in the Innovative Drug Market report?

Ans: The main players in the Innovative Drug Market are Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Allergan, Takeda, Boehringer Ingelheim

What are the Application segmentation covered in the Innovative Drug Market report?

Ans: The Applications covered in the Innovative Drug Market report are Hospitals and Clinics, Pharmacy, Others

What are the Type segmentation covered in the Innovative Drug Market report?

Ans: The Types covered in the Innovative Drug Market report are Biological Medicine, Chemical Medicine

Recommended Reports

Drug Market Segments

Drug Delivery & Asset

AI & Diagnostics

1 Study Coverage
1.1 Innovative Drug Product Introduction
1.2 Market by Type
1.2.1 Global Innovative Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Biological Medicine
1.2.3 Chemical Medicine
1.3 Market by Application
1.3.1 Global Innovative Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Innovative Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Innovative Drug Revenue by Region
2.2.1 Global Innovative Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Innovative Drug Revenue by Region (2019-2024)
2.2.3 Global Innovative Drug Revenue by Region (2025-2030)
2.2.4 Global Innovative Drug Revenue Market Share by Region (2019-2030)
2.3 Global Innovative Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Innovative Drug Sales by Region
2.4.1 Global Innovative Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Innovative Drug Sales by Region (2019-2024)
2.4.3 Global Innovative Drug Sales by Region (2025-2030)
2.4.4 Global Innovative Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Innovative Drug Sales by Manufacturers
3.1.1 Global Innovative Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Innovative Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Innovative Drug in 2023
3.2 Global Innovative Drug Revenue by Manufacturers
3.2.1 Global Innovative Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Innovative Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Innovative Drug Revenue in 2023
3.3 Global Key Players of Innovative Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Innovative Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Innovative Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Innovative Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Innovative Drug, Product Offered and Application
3.8 Global Key Manufacturers of Innovative Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Innovative Drug Sales by Type
4.1.1 Global Innovative Drug Historical Sales by Type (2019-2024)
4.1.2 Global Innovative Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Innovative Drug Sales Market Share by Type (2019-2030)
4.2 Global Innovative Drug Revenue by Type
4.2.1 Global Innovative Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Innovative Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Innovative Drug Revenue Market Share by Type (2019-2030)
4.3 Global Innovative Drug Price by Type
4.3.1 Global Innovative Drug Price by Type (2019-2024)
4.3.2 Global Innovative Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Innovative Drug Sales by Application
5.1.1 Global Innovative Drug Historical Sales by Application (2019-2024)
5.1.2 Global Innovative Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Innovative Drug Sales Market Share by Application (2019-2030)
5.2 Global Innovative Drug Revenue by Application
5.2.1 Global Innovative Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Innovative Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Innovative Drug Revenue Market Share by Application (2019-2030)
5.3 Global Innovative Drug Price by Application
5.3.1 Global Innovative Drug Price by Application (2019-2024)
5.3.2 Global Innovative Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Innovative Drug Market Size by Type
6.1.1 US & Canada Innovative Drug Sales by Type (2019-2030)
6.1.2 US & Canada Innovative Drug Revenue by Type (2019-2030)
6.2 US & Canada Innovative Drug Market Size by Application
6.2.1 US & Canada Innovative Drug Sales by Application (2019-2030)
6.2.2 US & Canada Innovative Drug Revenue by Application (2019-2030)
6.3 US & Canada Innovative Drug Market Size by Country
6.3.1 US & Canada Innovative Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Innovative Drug Sales by Country (2019-2030)
6.3.3 US & Canada Innovative Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Innovative Drug Market Size by Type
7.1.1 Europe Innovative Drug Sales by Type (2019-2030)
7.1.2 Europe Innovative Drug Revenue by Type (2019-2030)
7.2 Europe Innovative Drug Market Size by Application
7.2.1 Europe Innovative Drug Sales by Application (2019-2030)
7.2.2 Europe Innovative Drug Revenue by Application (2019-2030)
7.3 Europe Innovative Drug Market Size by Country
7.3.1 Europe Innovative Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Innovative Drug Sales by Country (2019-2030)
7.3.3 Europe Innovative Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Innovative Drug Market Size
8.1.1 China Innovative Drug Sales (2019-2030)
8.1.2 China Innovative Drug Revenue (2019-2030)
8.2 China Innovative Drug Market Size by Application
8.2.1 China Innovative Drug Sales by Application (2019-2030)
8.2.2 China Innovative Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Innovative Drug Market Size by Type
9.1.1 Asia Innovative Drug Sales by Type (2019-2030)
9.1.2 Asia Innovative Drug Revenue by Type (2019-2030)
9.2 Asia Innovative Drug Market Size by Application
9.2.1 Asia Innovative Drug Sales by Application (2019-2030)
9.2.2 Asia Innovative Drug Revenue by Application (2019-2030)
9.3 Asia Innovative Drug Sales by Region
9.3.1 Asia Innovative Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Innovative Drug Revenue by Region (2019-2030)
9.3.3 Asia Innovative Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Innovative Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Innovative Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Innovative Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Innovative Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Innovative Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Innovative Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Innovative Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Innovative Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Innovative Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Innovative Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Overview
11.2.3 Roche Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Roche Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sanofi Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Johnson & Johnson Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Information
11.5.2 Merck & Co. (MSD) Overview
11.5.3 Merck & Co. (MSD) Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Merck & Co. (MSD) Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck & Co. (MSD) Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Novartis Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Information
11.7.2 AbbVie Overview
11.7.3 AbbVie Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 AbbVie Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AbbVie Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Overview
11.8.3 Gilead Sciences Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Gilead Sciences Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gilead Sciences Recent Developments
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Information
11.9.2 GlaxoSmithKline (GSK) Overview
11.9.3 GlaxoSmithKline (GSK) Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 GlaxoSmithKline (GSK) Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline (GSK) Recent Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Overview
11.10.3 Amgen Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Amgen Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 AstraZeneca Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Information
11.12.2 Bristol-Myers Squibb Overview
11.12.3 Bristol-Myers Squibb Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Bristol-Myers Squibb Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Overview
11.13.3 Eli Lilly Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Eli Lilly Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Eli Lilly Recent Developments
11.14 Teva
11.14.1 Teva Company Information
11.14.2 Teva Overview
11.14.3 Teva Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Teva Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Teva Recent Developments
11.15 Bayer
11.15.1 Bayer Company Information
11.15.2 Bayer Overview
11.15.3 Bayer Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Bayer Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Bayer Recent Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Information
11.16.2 Novo Nordisk Overview
11.16.3 Novo Nordisk Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Novo Nordisk Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Novo Nordisk Recent Developments
11.17 Allergan
11.17.1 Allergan Company Information
11.17.2 Allergan Overview
11.17.3 Allergan Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Allergan Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Allergan Recent Developments
11.18 Takeda
11.18.1 Takeda Company Information
11.18.2 Takeda Overview
11.18.3 Takeda Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Takeda Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Takeda Recent Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Information
11.19.2 Boehringer Ingelheim Overview
11.19.3 Boehringer Ingelheim Innovative Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Boehringer Ingelheim Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Boehringer Ingelheim Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Innovative Drug Industry Chain Analysis
12.2 Innovative Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Innovative Drug Production Mode & Process
12.4 Innovative Drug Sales and Marketing
12.4.1 Innovative Drug Sales Channels
12.4.2 Innovative Drug Distributors
12.5 Innovative Drug Customers
13 Market Dynamics
13.1 Innovative Drug Industry Trends
13.2 Innovative Drug Market Drivers
13.3 Innovative Drug Market Challenges
13.4 Innovative Drug Market Restraints
14 Key Findings in The Global Innovative Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline(GSK )
Amgen Inc
Astrazeneca plc
Bristol–Myers Squibb
Eli Lilly
TEVA
Bayer
Novo Nordisk
Allergan plc
Takeda
Boehringer Ingelheim
List of Tables
    Table 1. Global Innovative Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Biological Medicine
    Table 3. Major Manufacturers of Chemical Medicine
    Table 4. Global Innovative Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Innovative Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Innovative Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Innovative Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Innovative Drug Revenue Market Share by Region (2019-2024)
    Table 9. Global Innovative Drug Revenue Market Share by Region (2025-2030)
    Table 10. Global Innovative Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Innovative Drug Sales by Region (2019-2024) & (K Units)
    Table 12. Global Innovative Drug Sales by Region (2025-2030) & (K Units)
    Table 13. Global Innovative Drug Sales Market Share by Region (2019-2024)
    Table 14. Global Innovative Drug Sales Market Share by Region (2025-2030)
    Table 15. Global Innovative Drug Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Innovative Drug Sales Share by Manufacturers (2019-2024)
    Table 17. Global Innovative Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Innovative Drug Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Innovative Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Innovative Drug Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Innovative Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Innovative Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug as of 2023)
    Table 23. Global Key Manufacturers of Innovative Drug, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Innovative Drug, Product Offered and Application
    Table 25. Global Key Manufacturers of Innovative Drug, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Innovative Drug Sales by Type (2019-2024) & (K Units)
    Table 28. Global Innovative Drug Sales by Type (2025-2030) & (K Units)
    Table 29. Global Innovative Drug Sales Share by Type (2019-2024)
    Table 30. Global Innovative Drug Sales Share by Type (2025-2030)
    Table 31. Global Innovative Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Innovative Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Innovative Drug Revenue Share by Type (2019-2024)
    Table 34. Global Innovative Drug Revenue Share by Type (2025-2030)
    Table 35. Innovative Drug Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Innovative Drug Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Innovative Drug Sales by Application (2019-2024) & (K Units)
    Table 38. Global Innovative Drug Sales by Application (2025-2030) & (K Units)
    Table 39. Global Innovative Drug Sales Share by Application (2019-2024)
    Table 40. Global Innovative Drug Sales Share by Application (2025-2030)
    Table 41. Global Innovative Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Innovative Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Innovative Drug Revenue Share by Application (2019-2024)
    Table 44. Global Innovative Drug Revenue Share by Application (2025-2030)
    Table 45. Innovative Drug Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Innovative Drug Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Innovative Drug Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Innovative Drug Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Innovative Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Innovative Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Innovative Drug Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Innovative Drug Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Innovative Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Innovative Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Innovative Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Innovative Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Innovative Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Innovative Drug Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Innovative Drug Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Innovative Drug Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Innovative Drug Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Innovative Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Innovative Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Innovative Drug Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Innovative Drug Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Innovative Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Innovative Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Innovative Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Innovative Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Innovative Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Innovative Drug Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Innovative Drug Sales by Country (2025-2030) & (K Units)
    Table 73. China Innovative Drug Sales by Type (2019-2024) & (K Units)
    Table 74. China Innovative Drug Sales by Type (2025-2030) & (K Units)
    Table 75. China Innovative Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Innovative Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Innovative Drug Sales by Application (2019-2024) & (K Units)
    Table 78. China Innovative Drug Sales by Application (2025-2030) & (K Units)
    Table 79. China Innovative Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Innovative Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Innovative Drug Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Innovative Drug Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Innovative Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Innovative Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Innovative Drug Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Innovative Drug Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Innovative Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Innovative Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Innovative Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Innovative Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Innovative Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Innovative Drug Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Innovative Drug Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Innovative Drug Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Innovative Drug Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Innovative Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Innovative Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Innovative Drug Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Innovative Drug Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Innovative Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Innovative Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Innovative Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Innovative Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Innovative Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Innovative Drug Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Innovative Drug Sales by Country (2025-2030) & (K Units)
    Table 107. Pfizer Company Information
    Table 108. Pfizer Description and Major Businesses
    Table 109. Pfizer Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Pfizer Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Pfizer Recent Developments
    Table 112. Roche Company Information
    Table 113. Roche Description and Major Businesses
    Table 114. Roche Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Roche Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Roche Recent Developments
    Table 117. Sanofi Company Information
    Table 118. Sanofi Description and Major Businesses
    Table 119. Sanofi Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Sanofi Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Sanofi Recent Developments
    Table 122. Johnson & Johnson Company Information
    Table 123. Johnson & Johnson Description and Major Businesses
    Table 124. Johnson & Johnson Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Johnson & Johnson Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Johnson & Johnson Recent Developments
    Table 127. Merck & Co. (MSD) Company Information
    Table 128. Merck & Co. (MSD) Description and Major Businesses
    Table 129. Merck & Co. (MSD) Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Merck & Co. (MSD) Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Merck & Co. (MSD) Recent Developments
    Table 132. Novartis Company Information
    Table 133. Novartis Description and Major Businesses
    Table 134. Novartis Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Novartis Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Novartis Recent Developments
    Table 137. AbbVie Company Information
    Table 138. AbbVie Description and Major Businesses
    Table 139. AbbVie Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. AbbVie Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. AbbVie Recent Developments
    Table 142. Gilead Sciences Company Information
    Table 143. Gilead Sciences Description and Major Businesses
    Table 144. Gilead Sciences Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Gilead Sciences Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Gilead Sciences Recent Developments
    Table 147. GlaxoSmithKline (GSK) Company Information
    Table 148. GlaxoSmithKline (GSK) Description and Major Businesses
    Table 149. GlaxoSmithKline (GSK) Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. GlaxoSmithKline (GSK) Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. GlaxoSmithKline (GSK) Recent Developments
    Table 152. Amgen Company Information
    Table 153. Amgen Description and Major Businesses
    Table 154. Amgen Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Amgen Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Amgen Recent Developments
    Table 157. AstraZeneca Company Information
    Table 158. AstraZeneca Description and Major Businesses
    Table 159. AstraZeneca Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. AstraZeneca Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. AstraZeneca Recent Developments
    Table 162. Bristol-Myers Squibb Company Information
    Table 163. Bristol-Myers Squibb Description and Major Businesses
    Table 164. Bristol-Myers Squibb Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Bristol-Myers Squibb Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Bristol-Myers Squibb Recent Developments
    Table 167. Eli Lilly Company Information
    Table 168. Eli Lilly Description and Major Businesses
    Table 169. Eli Lilly Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Eli Lilly Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Eli Lilly Recent Developments
    Table 172. Teva Company Information
    Table 173. Teva Description and Major Businesses
    Table 174. Teva Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. Teva Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Teva Recent Developments
    Table 177. Bayer Company Information
    Table 178. Bayer Description and Major Businesses
    Table 179. Bayer Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 180. Bayer Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Bayer Recent Developments
    Table 182. Novo Nordisk Company Information
    Table 183. Novo Nordisk Description and Major Businesses
    Table 184. Novo Nordisk Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 185. Novo Nordisk Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 186. Novo Nordisk Recent Developments
    Table 187. Allergan Company Information
    Table 188. Allergan Description and Major Businesses
    Table 189. Allergan Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 190. Allergan Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 191. Allergan Recent Developments
    Table 192. Takeda Company Information
    Table 193. Takeda Description and Major Businesses
    Table 194. Takeda Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 195. Takeda Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 196. Takeda Recent Developments
    Table 197. Boehringer Ingelheim Company Information
    Table 198. Boehringer Ingelheim Description and Major Businesses
    Table 199. Boehringer Ingelheim Innovative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 200. Boehringer Ingelheim Innovative Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 201. Boehringer Ingelheim Recent Developments
    Table 202. Key Raw Materials Lists
    Table 203. Raw Materials Key Suppliers Lists
    Table 204. Innovative Drug Distributors List
    Table 205. Innovative Drug Customers List
    Table 206. Innovative Drug Market Trends
    Table 207. Innovative Drug Market Drivers
    Table 208. Innovative Drug Market Challenges
    Table 209. Innovative Drug Market Restraints
    Table 210. Research Programs/Design for This Report
    Table 211. Key Data Information from Secondary Sources
    Table 212. Key Data Information from Primary Sources
List of Figures
    Figure 1. Innovative Drug Product Picture
    Figure 2. Global Innovative Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Innovative Drug Market Share by Type in 2023 & 2030
    Figure 4. Biological Medicine Product Picture
    Figure 5. Chemical Medicine Product Picture
    Figure 6. Global Innovative Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Innovative Drug Market Share by Application in 2023 & 2030
    Figure 8. Hospitals and Clinics
    Figure 9. Pharmacy
    Figure 10. Others
    Figure 11. Innovative Drug Report Years Considered
    Figure 12. Global Innovative Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Innovative Drug Revenue 2019-2030 (US$ Million)
    Figure 14. Global Innovative Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Innovative Drug Revenue Market Share by Region (2019-2030)
    Figure 16. Global Innovative Drug Sales 2019-2030 ((K Units)
    Figure 17. Global Innovative Drug Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Innovative Drug Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Innovative Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Innovative Drug Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Innovative Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Innovative Drug Sales YoY (2019-2030) & (K Units)
    Figure 23. China Innovative Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Innovative Drug Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Innovative Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Innovative Drug Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Innovative Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Innovative Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Innovative Drug in the World: Market Share by Innovative Drug Revenue in 2023
    Figure 30. Global Innovative Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Innovative Drug Sales Market Share by Type (2019-2030)
    Figure 32. Global Innovative Drug Revenue Market Share by Type (2019-2030)
    Figure 33. Global Innovative Drug Sales Market Share by Application (2019-2030)
    Figure 34. Global Innovative Drug Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Innovative Drug Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Innovative Drug Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Innovative Drug Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Innovative Drug Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Innovative Drug Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Innovative Drug Sales Share by Country (2019-2030)
    Figure 41. U.S. Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Innovative Drug Sales Market Share by Type (2019-2030)
    Figure 44. Europe Innovative Drug Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Innovative Drug Sales Market Share by Application (2019-2030)
    Figure 46. Europe Innovative Drug Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Innovative Drug Revenue Share by Country (2019-2030)
    Figure 48. Europe Innovative Drug Sales Share by Country (2019-2030)
    Figure 49. Germany Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 50. France Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 54. China Innovative Drug Sales Market Share by Type (2019-2030)
    Figure 55. China Innovative Drug Revenue Market Share by Type (2019-2030)
    Figure 56. China Innovative Drug Sales Market Share by Application (2019-2030)
    Figure 57. China Innovative Drug Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Innovative Drug Sales Market Share by Type (2019-2030)
    Figure 59. Asia Innovative Drug Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Innovative Drug Sales Market Share by Application (2019-2030)
    Figure 61. Asia Innovative Drug Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Innovative Drug Revenue Share by Region (2019-2030)
    Figure 63. Asia Innovative Drug Sales Share by Region (2019-2030)
    Figure 64. Japan Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 68. India Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Innovative Drug Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Innovative Drug Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Innovative Drug Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Innovative Drug Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Innovative Drug Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Innovative Drug Sales Share by Country (2019-2030)
    Figure 75. Brazil Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Innovative Drug Revenue (2019-2030) & (US$ Million)
    Figure 80. Innovative Drug Value Chain
    Figure 81. Innovative Drug Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Drug Discovery Assays Market Insights Forecast to 2030
Global Pharmaceutical Contract Development and Manufacturing Market Insights Forecast to 2030
Global Rheumatic Disorders Drug Market Insights Forecast to 2030
Global Blood Pressure Disorders Drug Market Insights Forecast to 2030
Global Drug Delivery in Cancer Market Insights Forecast to 2030
Global Patent Medicine Market Insights Forecast to 2030
Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030
Global AI for Pharma and Biotech Market Insights Forecast to 2030
Global Overactive Bladder Medication Market Insights Forecast to 2030
Global Fertility Medicines Market Insights Forecast to 2030
Global Lab Instruments Market Insights Forecast to 2030
Global Atherosclerosis Drugs Market Insights Forecast to 2030
Global Pricing Software Tools Market Insights Forecast to 2030
Global Biotech Modified Agricultural Product Market Insights Forecast to 2030
Global Warfarin Market Insights Forecast to 2030
Global Patent Drug Market Research Report 2025
Global Prescription Writing Software Market Insights Forecast to 2030
Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030
Global Marketing Analytics Tools and Software Market Insights Forecast to 2030
Global Derivatives Software Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions